Viviane Silva Pires Antonietti

Dr. Viviane Silva Pires Antonietti


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FRFrancisco Ramos-Martin
Francisco Ramos-Martin
CLClaudia Herrera Leon
Claudia Herrera Leon
VAViviane Silva Pires Antonietti
Viviane Silva Pires Antonietti
Pascal SonnetPascal Sonnet
Pascal Sonnet
CSCatherine Sarazin
Catherine Sarazin
NDNicola D'Amelio
Nicola D'Amelio
K11 is a synthetic peptide originating from the introduction of a lysine residue in position 11 within the sequence of a rationally designed antibacterial scaffold. Despite its remarkable antibacterial properties towards many ESKAPE bacteria and its optimal therapeutic index (320), a detailed description of its mechanism of action is missing. As most antimicrobial peptides act by destabilizing the membranes of the target organisms, we investigated the interaction of K11 with biomimetic membranes of various phospholipid compositions by liquid and solid-state NMR. Our data show that K11 can selectively destabilize bacterial biomimetic membranes and torque the surface of their bilayers. The same is observed for membranes containing other negatively charged phospholipids which might suggest additional biological activities. Molecular dynamic simulations reveal that K11 can penetrate the membrane in four steps: after binding to phosphate groups by means of the lysine residue at the N-terminus (anchoring), three couples of lysine residues act subsequently to exert a torque in the membrane (twisting) which allows the insertion of aromatic side chains at both termini (insertion) eventually leading to the flip of the amphipathic helix inside the bilayer core (helix flip and internalization).

19 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CLClaudia Herrera Leon
Claudia Herrera Leon
FRFrancisco Ramos-Martin
Francisco Ramos-Martin
HBHassan EL BTAOURI
Hassan EL BTAOURI
VAViviane Silva Pires Antonietti
Viviane Silva Pires Antonietti
Pascal SonnetPascal Sonnet
Pascal Sonnet
NDNicola D'Amelio
Nicola D'Amelio
Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.